Displaying drugs 9876 - 9894 of 9894 in total
Efonidipine
Efonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to L-type calcium channels [A7844, A32001]. It has also been studied in atherosclerosis...
Experimental
Matched International brands: … NZ-105 …
Matched Description: … This drug is also known as NZ-105, and several studies have been done on its pharmacokinetics in animals …
Matched Categories: … Membrane Transport Modulators …
Matched Description: … This drug is also known as NZ-105, and several studies have been done on its pharmacokinetics in animals …
Matched Categories: … Membrane Transport Modulators …
GDP-alpha-D-mannuronic acid
Experimental
Cpad
Experimental
Histidyl-Adenosine Monophosphate
Experimental
Adenylosuccinic acid
Experimental
S-adenosyl-L-homocysteine
5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
Experimental
SB-409513
Experimental
Selenazole-4-carboxyamide-adenine dinucleotide
Experimental
5,10-Dimethylene Tetrahydromethanopterin
Experimental
Clorobiocin
Clorobiocin is an aminocoumarin antibiotic, similar to novobiocin and coumermycin A1.
Experimental
Aclarubicin
Investigational
Tryptophanyl-5'amp
Experimental
Succinyl-Coenzyme A
Experimental
Propanoyl-CoA
Experimental
Acetoacetyl-CoA
Experimental
5-Mercaptoethanol-2-decenoyl-coenzyme A
Experimental
Displaying drugs 9876 - 9894 of 9894 in total